Quantcast

Latest Memorial Sloan–Kettering Cancer Center Stories

2010-01-06 09:10:00

NEW YORK, Jan. 6 /PRNewswire/ -- On January 31 and February 6, 2010, thousands of indoor cyclists will team up in the ride against cancer at the fourth annual Cycle for Survival fundraiser, benefiting research on rare cancers at Memorial Sloan-Kettering Cancer Center. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/mskcc/41688/ (Logo: http://www.newscom.com/cgi-bin/prnh/20100106/NY33181LOGO ) A total of 400 teams of up to eight...

2009-12-25 22:10:16

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan-Kettering Cancer Center shows that circulating tumor cells "“ cancer cells that break away from a primary tumor and disseminate to other areas of the body "“ can also return to and grow in their tumor of origin, a newly discovered process called...

2009-11-17 17:19:03

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan-Kettering Cancer Center finds that while clinicians' and patients' reporting of treatment side effects are very different from each other, together they provide a...

2009-10-20 09:20:00

NEW YORK, Oct. 20 /PRNewswire/ -- The Society of Memorial Sloan-Kettering Cancer Center (MSKCC) announces the launch of PARK AVENUE POTLUCK CELEBRATIONS (ISBN: 978-0-8478-3344-3; $35.00; OCTOBER 2009), the highly anticipated sequel to its best selling cookbook, PARK AVENUE POTLUCK. Created and authored by members of The Society, the cookbook is released nationwide by Rizzoli on October 20, 2009 and offers advice on how to celebrate in style with a compilation of 80 sensational recipes,...

2009-10-13 16:21:11

Breast"“conserving surgery offered to the majority of patients There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study found that breast-conserving surgery was presented and provided in the majority of patients evaluated. Surgeon recommendations, patient decisions, and failure of breast-conserving surgery were all found...

2009-09-28 13:34:00

MENLO PARK, Calif. and NEW YORK and BIRMINGHAM, Ala., Sept. 28 /PRNewswire/ -- The U.S. Food & Drug Administration has announced the approval of pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Research on drugs of this class began in the 1950s at SRI International. A subsequent scientific collaboration among SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute led to clinical trials on related compounds...

2009-09-25 17:24:00

MENLO PARK, Calif., NEW YORK and BIRMINGHAM, Ala., Sept. 25 /PRNewswire/ -- The U.S. Food & Drug Administration has announced the approval of pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Research on drugs of this class began in the 1950s at SRI International. A subsequent scientific collaboration among SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute led to clinical trials on related compounds...

2009-07-28 09:30:00

Weill Cornell Medical College Cost Effectiveness Study Looks at Potential Value of New Genetic Test for Guiding Chemotherapy Treatment For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk...

2009-07-08 06:00:00

EAST HAMPTON, N.Y., July 8 /PRNewswire-USNewswire/ -- The Max Cure Foundation -- a non-profit organization whose mission is to fund pediatric cancer causes -- announced today its first charity benefit, the first annual "Roar for a Cure" Carnival and family fun day, to take place on Saturday, August 22, from 2:00 - 6:00 p.m. (rain date: Sunday, August 23) on the grounds of the East Hampton Indoor Tennis Club, 175 Daniels Hole Road, East Hampton, N.Y. The outdoor event will have fun-filled...

2009-07-06 13:37:12

New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered. The findings support the study of therapies that target this survival capacity and force the death of latent breast cancer cells before they get a chance to metastasize, or spread "“ a problem that accounts for a majority of breast...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related